Project Grant 2208248
Award Date
1/15/23
Completion Date
6/30/23
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Woodstock, GA 30188, USA
Similar Awards
The National Science Foundation awarded Cardiophi LLC $532,000 under the Technology, Innovation, and Partnerships program to develop an artificial intelligence solution for the automated interpretation of electrocardiograms. The project aims to refine existing deep learning-based algorithms for detecting irregular heartbeats, develop methods for predicting the onset of cardiac arrhythmias, and create interpretable and explainable tools to provide insights from ECG signals to clinicians....
The National Science Foundation (NSF) awarded a $275,000 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to KAI TECH LLC. The funding supports the development of an advanced software system called ECG-AID for automated electrocardiogram (ECG) analysis and interpretation. The ECG-AID prototype integrates a comprehensive ECG database, Z-score-based assessments, and machine-learning techniques to enhance the...
This $275,000 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and validation of an automated method for continuous post-operative cardiac rhythm diagnosis. The project, led by Atrility Medical, Inc., aims to improve the accuracy and accessibility of post-operative rhythm monitoring through the use of high-quality atrial electrogram signals. The anticipated outcome is a real-time, continuous...
This $150,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program aims to develop technologies to improve cardiac care for patients in rural and tribal areas of Arizona. Clemson University is partnering with Northern Arizona University and community leaders to plan an integrated remote heart monitoring system. The system will utilize deep learning and Markov-based methods to predict deterioration in symptoms for patients with conditions...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,153 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Safebeat RX Inc. The funding supports the development of a novel, smartwatch-enabled technology that allows patients with low-risk atrial fibrillation to safely initiate antiarrhythmic medications at home. The technology analyzes post-drug ECG data taken by patients using a machine learning algorithm and provides this information to...
This National Science Foundation (NSF) Cooperative Agreement award, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $999,553 to Dynocardia, Inc. to develop advanced computer vision and artificial intelligence algorithms for motion artifact correction in their Vitrack wearable blood pressure monitoring device. The project aims to improve the accuracy and reliability of Vitrack's continuous, non-invasive blood pressure measurements in clinical settings, where...
The National Science Foundation (NSF) awarded a $1,000,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to the Research Foundation of the City University of New York (RFCUNY) for the "PARTNER: AI/ML-DRIVEN EDGE COMPUTING FOR CARDIOVASCULAR DISEASE DIAGNOSIS/MECHANISM STUDY" project. This collaborative research effort between RFCUNY's City College of New York (CCNY) and the AI Institute for Future Edge Networks and Distributed Intelligence...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I award provides $275,000 to Neuraltrak, Inc. to develop and validate a method for continuous, real-time cardiac rhythm diagnosis and display using high-quality atrial electrogram data. The project aims to address limitations of current post-operative cardiac rhythm monitoring approaches, which often fail to accurately interpret rhythm due to poor atrial signal quality and patient variability. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $295,895 to Ricovr Healthcare Inc. to develop a rapid, low-cost, point-of-care (POC) diagnostic platform for quantitative measurement of placental growth factor (PlGF) to predict and detect pre-eclampsia. The goal is to create an objective, affordable POC tool to improve the clinical diagnosis and monitoring of pre-eclampsia, which...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $343,203 to Cyion Technologies LLC to develop a novel in vitro electrophysiology system for high-throughput measurement of intracellular action potential (IAP) in human-derived cardiomyocytes. The system leverages a 3D nanoelectrode array (NEA) technology to enable scalable recordings of IAP signals from many individual cardiomyocytes. This...